B, I., R, G., A, V., AI, C., E, M., R, K., & A, T. (2020). Myelin oligodendrocyte glycoprotein antibody associated central nervous system demyelinating disease: A tertiary center experience from Turkey. Multiple sclerosis and related disorders, 44, 102376. https://doi.org/10.1016/j.msard.2020.102376
Chicago Style (17th ed.) CitationB, Inan, Gocmen R, Vural A, Colpak AI, Meinl E, Karabudak R, and Tuncer A. "Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience from Turkey." Multiple Sclerosis and Related Disorders 44 (2020): 102376. https://doi.org/10.1016/j.msard.2020.102376.
MLA (9th ed.) CitationB, Inan, et al. "Myelin Oligodendrocyte Glycoprotein Antibody Associated Central Nervous System Demyelinating Disease: A Tertiary Center Experience from Turkey." Multiple Sclerosis and Related Disorders, vol. 44, 2020, p. 102376, https://doi.org/10.1016/j.msard.2020.102376.